Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.020
-0.040 (-3.77%)
May 7, 2025, 4:00 PM EDT - Market closed
Standard BioTools Revenue
Standard BioTools had revenue of $40.80M in the quarter ending March 31, 2025, a decrease of -10.42%. This brings the company's revenue in the last twelve months to $169.69M, up 33.86% year-over-year. In the year 2024, Standard BioTools had annual revenue of $174.43M with 64.03% growth.
Revenue (ttm)
$169.69M
Revenue Growth
+33.86%
P/S Ratio
2.34
Revenue / Employee
$207,441
Employees
818
Market Cap
387.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 174.43M | 68.09M | 64.03% |
Dec 31, 2023 | 106.34M | 8.39M | 8.57% |
Dec 31, 2022 | 97.95M | -32.63M | -24.99% |
Dec 31, 2021 | 130.58M | -7.56M | -5.47% |
Dec 31, 2020 | 138.14M | 20.90M | 17.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Abbott Laboratories | 42.34B |
LAB News
- 23 hours ago - Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 1 day ago - Standard BioTools Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 13 days ago - Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 - GlobeNewsWire
- 15 days ago - Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025 - GlobeNewsWire
- 2 months ago - Standard BioTools to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 - GlobeNewsWire